PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,300 stories, page 107 of 605

Advanced search
🌍discoverynews.google.com

Budget for specialty pharmaceutical benefits set at €6.73 billion

The Brussels TimesOriginal source
🌍discoverynews.google.com

Price to earnings forward of Beijing Science Sun Pharmaceutical Co., Ltd. Class A – SZSE:300485

tradingview.comOriginal source
🌍discoverynews.google.com

ADRX IPO News - siRNA biotech ADARx Pharmaceuticals files for a $100 million IPO

renaissancecapital.comOriginal source
🌍discoverynews.google.com

Health Care Down on Retreat From Risky Biotech Area - Health Care Roundup

marketscreener.comOriginal source
🌍discoverynews.google.com

Pharmaceutical Temperature-Controlled Shipping Boxes Market Outlook to 2035

IndexBoxOriginal source
🌍discoverynews.google.com

Louisiana et al. v. Food and Drug Administration: A case working its way through federal courts poses a dangerous threat to abortion access nationwide.

National Women's Law CenterOriginal source
🌍discoverynews.google.com

Novartis’ experimental cardiovascular drug fails a pivotal study

STATOriginal source
🌍Industrymatinasbiopharma.com

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Matinas BioPharmaOriginal source
🌍discoverynews.google.com

FDA rallies HRT manufacturers amid US-wide estradiol patch shortage

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.com

Krystal Biotech (NASDAQ: KRYS) holder to sell 25,000 founders shares

Stock TitanOriginal source
🌍discoverynews.google.com

Krystal Biotech (KRYS) insider moves to sell 2017 shares in a multimillion-dollar deal

Stock TitanOriginal source
🌍discoverynews.google.com

Novartis announces Lp(a)HORIZON Phase III topline results for pelacarsen in patients with elevated Lp(a) and established cardiovascular disease (CVD)

NovartisOriginal source
🌍Regulatoryargentina.gob.ar

ANMAT emitió una Carta de Advertencia a UGAL FARMACÉUTICA S.A. por incumplimientos a las Buenas Prácticas de Fabricación

ANMAT NoticiasOriginal source
🌍discoverynews.google.com

FDA Clears IND for Acepodia's Dual-Payload ADC ACE723

BioPharm InternationalOriginal source
🌍discoverynews.google.com

How Virtus Lifesci Biotech Products Etf (BBP) Affects Rotational Strategy Timing

Stock Traders DailyOriginal source
🌍discoverynews.google.com

Price to sales forward of CH Biotech R&D Co., Ltd. – TWSE:6534

tradingview.comOriginal source
🌍discoverynews.google.com

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?

The Motley FoolOriginal source
🌍discoverynews.google.com

Cipla Partners With Qilu Pharmaceutical to Commercialize a Keytruda Biosimilar in the US

BioPharm InternationalOriginal source
🌍discoverynews.google.com

Gan & Lee Pharmaceuticals

Fierce BiotechOriginal source
🌍discoverynews.google.com

FDA green light for Zanvastro in Alexander disease

The Pharma LetterOriginal source
🌍Regulatoryargentina.gob.ar

ANMAT presentó la experiencia argentina en vigilancia y control post comercialización de dispositivos médicos

ANMAT NoticiasOriginal source
🌍discoverynews.google.com

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?

The Globe and MailOriginal source
🌍discoverynews.google.com

Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?

AOL.comOriginal source
🌍discoverynews.google.com

Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $48.00 at UBS Group

MarketBeatOriginal source
🌍discoverynews.google.com

BeOne (ONC) Secured a Pharmaceutical-Tariff Exemption After More than $1B of U.S. Manufacturing Investment. Are the Pricing Concessions Worth It?

Yahoo FinanceOriginal source
🌍Industryeledon.com

Porcine kidney xenotransplantation as a bridge to allotransplantation: a first-in-human study

Eledon PharmaceuticalsOriginal source
🌍discoverynews.google.com

The Goldman Sachs Group Issues Pessimistic Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price

MarketBeatOriginal source
🌍discoverynews.google.com

Jos Vergeest appointed at Symbiosis, bringing three decades of pharmaceutical experience.

Cleanroom TechnologyOriginal source
🌍discoverynews.google.com

Rare Brain Disorder Gets Its First FDA Drug Approval

MedPage TodayOriginal source
🌍discoverynews.google.com

How Pharma Will Navigate the NDC-12 Transition

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.com

Novartis pauses autoimmune CAR T trials following three deaths

Drug Discovery NewsOriginal source
🌍discoverynews.google.com

H.C. Wainwright Maintains Legend Biotech(LEGN.US) With Buy Rating, Maintains Target Price $65

MoomooOriginal source
🌍discoverynews.google.com

Police response ‘insufficient’ for crimes against pharmacies, report owners

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.com

Call to expand shingles vaccine following cardiovascular research

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.com

FDA Approves Zanvastro | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.com

Maharashtra FDA strikes again, closes canteen at Thane Government Hospital after cockroach found in patient’s

India.comOriginal source
🌍discoverynews.google.com

Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases

Genetic Engineering and Biotechnology NewsOriginal source
🌍discoverynews.google.com

News | Biotech firm inks office deal in South San Francisco

CoStarOriginal source
🌍discoverynews.google.com

Cockroach found in patient’s meal; FDA flags violations, shuts Thane hospital canteen

Mathrubhumi EnglishOriginal source
🌍discoverynews.google.com

Pfizer’s Tilrekimig Eczema Trial: A Fresh Phase 3 Catalyst for PFE Investors

TipRanksOriginal source
🇺🇸Devicesnews.medtronic.com

Medtronic executives to speak at upcoming investor conferences

Medtronic Global NewsOriginal source
🌍discoverynews.google.com

This Biotech Wins a Big FDA Approval. Why Wall Street Is Shrugging.

Barron'sOriginal source
🌍discoverynews.google.com

Trailing rivals, AbbVie scores win with dual-acting myeloma drug

BioPharma DiveOriginal source
🌍discoverynews.google.com

Registration open for Sacramento biotech summit at Aggie Square

Sacramento City ExpressOriginal source
🌍discoverynews.google.com

Genencell's Book Value Hits Zero Amid Allegations Kim Seung-won Sought Clinical Approval; Sejong Medical Faces Delisting

finance.biggo.comOriginal source
🌍discoverynews.google.com

AI Is Revolutionizing Biotech. Can Regulation Keep Up?

realclearhealth.comOriginal source
🌍discoverynews.google.com

Pharma Pulse: MFN Expansion, GoodRx's Family Plan, CSafe's Reusable Cover

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.com

Teva Pharmaceutical Industries Ltd. Upgraded to Investment-Grade by S&P Global Ratings

Quiver QuantitativeOriginal source
🌍discoverynews.google.com

A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths

BenzingaOriginal source
🌍discoverynews.google.com

Daiichi unit American Regent recalls 3 epinephrine batches on particulate, leakage concerns

Fierce PharmaOriginal source
🌍Researchnews.uci.edu

Paul Cooper named chief of UC Irvine Police Department

University of California IrvineOriginal source
🇩🇪Researchuni-heidelberg.de

School-Based Prevention Programs for Gaming Disorder and Problematic Online Habits

Heidelberg UniversityOriginal source
🌍discoverynews.google.com

VA secures $10B+ in pharmaceutical price reductions so far in FY 2026

The Killeen Daily HeraldOriginal source
🌍discoverynews.google.com

Russia Attacks Teva Pharmaceutical Company and World Health Organization Warehouse in Ukraine

Kyiv PostOriginal source
🇺🇸Researchwi.mit.edu

AI model decodes the language cells use to communicate

Whitehead Institute NewsOriginal source
🌍discoverynews.google.com

Former I-Mab chief Joan Shen's NeuShen banks $80M+ for 3 brain-health drugs

Endpoints NewsOriginal source
🌍discoverynews.google.com

Veraxa Biotech stock rises after naming Raju Willener as CFO By Investing.com

Investing.com CanadaOriginal source
🌍discoverynews.google.com

Drug Digest: Expedited Regulatory Pathways for Biologics

BioPharm InternationalOriginal source
🌍discoverynews.google.com

Cipla Announces Exclusive Partnership with Qilu Pharmaceutical for the Licensing and Supply of Biosimilar to Keytruda(R) (Pembrolizumab) in the US

marketscreener.comOriginal source
🌍discoverynews.google.com

From Indonesia to the world: support Beta Pharmacon’s manufacturing excellence with GEA granulation technology

Manufacturing ChemistOriginal source